SCHEMBL31875233

SCHEMBL31875233

NCc1nc2cnccc2[nH]1

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ CACNA1H O95180 1/20 0.44
▸ KDM4C Q9H3R0 1/20 0.40
▸ KRAS P01116 1/20 0.38
▸ DDAH1 O94760 1/20 0.38
▸ POLB P06746 1/20 0.38
▸ PDE3B Q13370 1/20 0.38
▸ PDE3A Q14432 1/20 0.38
▸ AOC1 P19801 2/20 0.37
▸ AOC3 Q16853 2/20 0.37
▸ HTR6 P50406 2/20 0.37
▸ LOXL2 Q9Y4K0 1/20 0.36
▸ DRD4 P21917 1/20 0.36
▸ GAA P10253 1/20 0.36
▸ RAD52 P43351 1/20 0.36
▸ UBE2N P61088 1/20 0.36
▸ IDO1 P14902 1/20 0.36
▸ EGFR P00533 1/20 0.35
▸ ACHE P22303 1/20 0.35
▸ CYP2A6 P11509 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4072911 1.00 CACNA1H (0.44) CACNA1HKDM4CKRASDDAH1POLB
Hydrochloric Acid SCHEMBL27147079 0.98 CACNA1H (0.42) CACNA1HKDM4CKRASDDAH1POLB
SCHEMBL588512 0.85 KRAS (0.51) CACNA1HKRAS
Hydrochloric Acid SCHEMBL28964805 0.84 KRAS (0.50) CACNA1HKRAS
SCHEMBL5806722 0.81 TDP1 (0.49) KDM4CKRASDDAH1POLBPDE3B
SCHEMBL7578581 0.81 KDM4C (0.40) KDM4CKRASDDAH1POLBPDE3B
SCHEMBL10206036 0.81 DDAH1 (0.59) KDM4CKRASDDAH1POLBPDE3B
SCHEMBL9569918 0.79 KDM4C (0.48) KDM4CKRASPOLBPDE3BPDE3A
SCHEMBL9851482 0.79 KDM4C (0.63) KDM4CDDAH1POLB
SCHEMBL9598111 0.79 KDM4C (0.44) KDM4CKRASPOLBRAD52

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026101698-A1 HEPCIDIN MIMETIC COMPOUNDS AND USES THEREOF PROTAGONIST THERAPEUTICS, INC. (US) 2026-05-15 — — WO disclosed
Send feedback